Peijia Medical's TaurusTrio TAV System Accepted for NMPA Review in China
CompanyMedical Device

Peijia Medical’s TaurusTrio TAV System Accepted for NMPA Review in China

HighTide Therapeutics' HTD1801 Shows Positive Phase III Results in Type 2 Diabetes Treatment
CompanyDrug

HighTide Therapeutics’ HTD1801 Shows Positive Phase III Results in Type 2 Diabetes Treatment

Zhuhai Beihai Biotech Gains NMPA Clinical Clearance for Innovative Peptide-Drug Conjugate BH259
CompanyDrug

Zhuhai Beihai Biotech Gains NMPA Clinical Clearance for Innovative Peptide-Drug Conjugate BH259

Novlead Biotech Secures Series C Financing to Expand NO Inhalation Therapy Device Production
CompanyDeals

Novlead Biotech Secures Series C Financing to Expand NO Inhalation Therapy Device Production

Chromatin Bioscience Collaborates with Astellas Pharma to Design Cell-Selective Synthetic Promoters
CompanyDeals

Chromatin Bioscience Collaborates with Astellas Pharma to Design Cell-Selective Synthetic Promoters

MSD's Gardasil 9 Approved in China for Males Aged 16 to 26
CompanyDrug

MSD’s Gardasil 9 Approved in China for Males Aged 16 to 26

NHC Urges Hospitals to Establish Healthy Weight Management Clinics by June
Policy / Regulatory

NHC Urges Hospitals to Establish Healthy Weight Management Clinics by June

Mabwell and DP Technology Collaborate to Build Biopharma AI Platform for Drug Development
CompanyDeals

Mabwell and DP Technology Collaborate to Build Biopharma AI Platform for Drug Development

Bristol Myers Squibb Wins FDA Approval for Opdivo-Yervoy Combo in First-Line HCC Treatment
CompanyDrug

Bristol-Myers Squibb Wins FDA Approval for Opdivo-Yervoy Combo in First-Line HCC Treatment

Jiangxi Institute of Biological Products Files for Hong Kong IPO Amid Strong Market Position
CompanyDeals

Jiangxi Institute of Biological Products Files for Hong Kong IPO Amid Strong Market Position

Zhaoke Ophthalmology Launches Phase II Study for Brimochol PF in Presbyopia Treatment
CompanyDeals

Zhaoke Ophthalmology Launches Phase II Study for Brimochol PF in Presbyopia Treatment

CSPC Pharmaceutical Gains NMPA Approval for Clinical Trial of SYH2046 in Heart Failure
CompanyDrug

CSPC Pharmaceutical Gains NMPA Approval for Clinical Trial of SYH2046 in Heart Failure